WES data from 165 tumor/germline samples with muscle invasive bladder cancer.

Dataset ID Technology Samples
EGAD00001006239 Illumina NovaSeq 6000,NextSeq 500 330

Dataset Description

In this study, a total of 300 patients with MIBC receiving chemotherapy were included; 62 received NAC before cystectomy and 245 received first-line chemotherapy upon detection of locally-advanced (T4b) or metastatic disease. Treatment response, defined as pathological downstaging (< pTa,CIS,N0) after NAC or complete or partial response after first-line treatment (RECIST criteria). WES was performed using DNA from 165 tumors (76x median coverage) and associated germline DNA (46x median coverage). Data provided here consist of 5,828 fastq files for WES.

Who controls access to this dataset

For each dataset that requires controlled access, there is a corresponding Data Access Committee (DAC) who determine access permissions. Access to actual data files is not managed by the EGA. If you need to request access to this data set, please contact:

MOMA - Bladder group DAC
Contact person: Lars Dyrskj√łt
Email: lars [at] clin [dot] au [dot] dk
More details: EGAC00001001642


You don't have access to the download section.